NCT05681039 2026-03-02Phase 2 Trial of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab in Patients With Newly Diagnosed PD-L1 CPS Positive Resectable Stage 3-4 Oral Cavity Squamous Cell Carcinoma (OCSCC).M.D. Anderson Cancer CenterPhase 2 Recruiting29 enrolled
NCT03708224 2025-01-28Preoperative Immunotherapy in Patients With Squamous Cell Carcinoma of the Head and NeckUniversity of California, San FranciscoPhase 2 Recruiting55 enrolled